Vertex Pharmaceuticals is executing a pivotal transition year, evolving from a CF-dominated biotech to a multi-franchise ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the second quarter ended June 30, 2026. "The second quarter reflected ...

CASGEVY is a non-viral, ex vivo, CRISPR/Cas9 gene-edited cell therapy for eligible patients with SCD or TDT that has been ...

A survey by A Mission for Michael ranks Juniper at Vertex Sky Bar in Rapid City as the third-best free or public urban sunset ...

Everforthtm ECS®, a provider of advanced technology solutions in data and AI, cybersecurity, and enterprise transformation, and the Federal Government Segment of Everforth, Inc. , today announced the ...

This repository gives a verified 14-vertex counterexample to Written on the Wall II Conjecture 200. The conjecture says that a finite connected simple graph (G), with more than one vertex, should have ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Please note this event is being recorded. I would now like to turn the conference over to Ms. Susie Lisa. Please go ahead. Thanks, Chuck. Good afternoon, everyone, and thank you for joining us on ...

Vertex has secured a label expansion through the FDA's Commissioner’s National Priority Voucher (CNPV) program, which allows children as young as 2 years of age to receive the gene therapy Casgevy for ...

The U.S. Food and Drug Administration cleared the world's first CRISPR-based gene therapy for use in children as young as two years old on July 1, 2026 — an expansion that places a potentially ...

State-of-the-art gene therapy provides new treatment option for children 2 years and older with life-threatening blood disorder Silver Spring, MD, July 01, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and ...

Credit: VentureBeat made with OpenAI ChatGPT-Images-2.0 Anthropic is restoring global access to its most powerful generally released AI model yet, Claude Fable 5, today, after the U.S. Department of ...